Cargando…

Increased expression of insulin-like growth factor-1 receptor predicts poor prognosis in patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a lethal disease worldwide. In this study, we sought to explore the expression of insulin-like growth factor-1 receptor (IGF-1R) and its prognostic value in HCC. The expressions of IGF-1R mRNA and protein were estimated using quantitative real-time polymerase chain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhiquan, Lei, Bao, Chai, Wei, Liu, Ruhai, Li, Tiejun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946458/ https://www.ncbi.nlm.nih.gov/pubmed/31689787 http://dx.doi.org/10.1097/MD.0000000000017680

Ejemplares similares

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017)

High expression of guanine nucleotide-binding protein-like-3-like is associated with poor prognosis in esophageal cancer
por: Dai, Guihong, et al.
Publicado: (2021)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case–control study
por: Li, Zhonghu, et al.
Publicado: (2016)

Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients
por: Zhao, Yang, et al.
Publicado: (2015)

Increased Serum Levels of Macrophage Inflammatory Protein-3α and Cystatin A Predict a Poor Prognosis of Nasopharyngeal Carcinoma
por: Cai, Yonglin, et al.
Publicado: (2014)

Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review
por: Liu, Sizhe, et al.
Publicado: (2023)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
por: Bi, Cheng-wei, et al.
Publicado: (2019)

High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis
por: He, Shujin, et al.
Publicado: (2019)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis
por: Wang, Anmei, et al.
Publicado: (2021)

Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab: A case report
por: Song, Peng, et al.
Publicado: (2017)

Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study
por: Wang, Lei, et al.
Publicado: (2023)

Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma: A meta-analysis
por: Zhang, Shizhen, et al.
Publicado: (2016)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments
por: Zhao, Xiayan, et al.
Publicado: (2020)

Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma
por: Gong, Youwei, et al.
Publicado: (2020)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database
por: Zelong, Yang, et al.
Publicado: (2021)

Overexpression of fatty acid desaturase 3 predicts poor prognosis in head and neck squamous cell carcinoma
por: Su, Kuiwei, et al.
Publicado: (2022)

Impact of regulatory T cells on the prognosis of hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Shi, Xinhui, et al.
Publicado: (2021)

High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma
por: Wang, Qiang, et al.
Publicado: (2015)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA)
por: Liu, Rui, et al.
Publicado: (2015)

Jagged1 modulated tumor-associated macrophage differentiation predicts poor prognosis in patients with invasive micropapillary carcinoma of the breast
por: Liu, Hang, et al.
Publicado: (2017)

FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma
por: Fu, Taozhu, et al.
Publicado: (2023)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Overexpression of NEK3 is associated with poor prognosis in patients with gastric cancer
por: Cao, Yongfeng, et al.
Publicado: (2018)

Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis
por: Cui, Kai, et al.
Publicado: (2020)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database
por: Chen, Shicheng, et al.
Publicado: (2022)

High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved
por: Luo, Yihuan, et al.
Publicado: (2016)

Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer
por: Li, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lefrknijdkd5ognl7vaop9fc9k